학술논문
Survival of patients with multiple myeloma in first-line treatment: thalidomide, dexamethasone and zoledronic acid. Report of the National Cancer Institute of México (INCan)
Document Type
Abstract
Author
Espinoza-Zamora, J.R.; Labardini-Méndez, J.R.; Zapata-Canto, N.P.; Aguilar-Rodríguez, M.; Vieyra-García, M.; Sosa-Espinoza, A.; González C, L.; Fierro-García, M.G.; Nolasco-Medina, D.B.; Ríos-Contreras, J.G.; Torres-Flores, J.C.; Espinoza-Zamora, V.J.; Velázquez-Figueroa, J.M.; Lozano-Zavaleta, V.; Candelaria-Hernández, G.M.; Oñate-Ocaña, L.F.; Cervera-Ceballos, E.E.; Meneses-García, A.A.
Source
In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e261-e261
Subject
Language
ISSN
2152-2650